Healthcare

Opus Genetics to Participate in Upcoming Investment Conferences

RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (the “Company” or “Opus Genetics”),…

1 month ago

NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference

BELTSVILLE, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and…

1 month ago

Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update

 —Nebokitug PSC Phase 3 Design Near Completion Following Positive FDA Feedback— —Regulatory Alignment Advances, with EMA Guidance Supporting a Single…

1 month ago

Konica Minolta Healthcare Reinforces Leadership in Advanced Radiography with Seven Scientific Presentations on Dynamic Digital Radiography at RSNA 2025

Dynamic Digital Radiography pulmonary Konica Minolta's IWS workstation processes and quantifies Dynamic Digital Radiography diaphragmatic motion data. WAYNE, N.J., Nov.…

1 month ago

Media advisory: Shriners Hospitals for Children Canada Opens Its Doors to the Public on November 29 in Honour of Its 100th Anniversary

Open House – Celebrating 100 Years of Care Open House – Celebrating 100 Years of Care MONTREAL, Nov. 20, 2025…

1 month ago

Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Sol-Gel intends to pursue high-frequency BCC as an additional indication for its lead drug candidate SGT-610, which, if approved, could…

1 month ago

CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally

Curium and CapVest have announced the recapitalization of Curium via a new Continuation Vehicle The transaction values Curium at circa…

1 month ago

Axsome Therapeutics to Participate in Upcoming Investor Conferences

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era…

1 month ago

MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid® Facility;…

1 month ago

Sagimet Biosciences to Participate in the 8th Annual Evercore ISI Healthcare Conference

SAN MATEO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel…

1 month ago